324 related articles for article (PubMed ID: 19699336)
1. Role of myeloperoxidase as predictor of systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention.
Samimi-Fard S; Dominguez-Rodriguez A; Abreu-Gonzalez P; Enjuanes-Grau C; Blanco-Palacios G; Hernandez-Baldomero IF; Bosa-Ojeda F; Marrero-Rodríguez F
Am J Cardiol; 2009 Sep; 104(5):634-7. PubMed ID: 19699336
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock.
Dominguez-Rodriguez A; Samimi-Fard S; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
Am J Cardiol; 2008 Jun; 101(11):1537-40. PubMed ID: 18489929
[TBL] [Abstract][Full Text] [Related]
3. Grade 3 ischemia on admission electrocardiogram and chest pain duration predict failure of ST-segment resolution after primary percutaneous coronary intervention for acute myocardial infarction.
McGehee JT; Rangasetty UC; Atar S; Barbagelata NN; Uretsky BF; Birnbaum Y
J Electrocardiol; 2007 Jan; 40(1):26-33. PubMed ID: 17067628
[TBL] [Abstract][Full Text] [Related]
4. Grade 3 ischemia on the admission electrocardiogram predicts failure of ST resolution and of adequate flow restoration after primary percutaneous coronary intervention for acute myocardial infarction.
Wolak A; Yaroslavtsev S; Amit G; Birnbaum Y; Cafri C; Atar S; Gilutz H; Ilia R; Zahger D
Am Heart J; 2007 Mar; 153(3):410-7. PubMed ID: 17307421
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
Marshall CJ; Nallaratnam M; Mocatta T; Smyth D; Richards M; Elliott JM; Blake J; Winterbourn CC; Kettle AJ; McClean DR
Am J Cardiol; 2010 Aug; 106(3):316-22. PubMed ID: 20643239
[TBL] [Abstract][Full Text] [Related]
6. Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction.
Yunoki K; Naruko T; Komatsu R; Shirai N; Nakagawa M; Sugioka K; Ikura Y; Kusano KF; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
Am J Cardiol; 2010 Apr; 105(7):922-9. PubMed ID: 20346307
[TBL] [Abstract][Full Text] [Related]
7. Early reduction of QT dispersion after primary percutaneous intervention in ST-segment elevation acute myocardial infarction. Mechanisms and clinical implications.
Jiménez-Candil J; Hernández Hernández J; Aguero VL; Martín A; Martín F; Moríñigo JL; Martín-Luengo C
Cardiology; 2009; 113(3):172-9. PubMed ID: 19136825
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Terkelsen CJ; Sørensen JT; Kaltoft AK; Nielsen SS; Thuesen L; Bøtker HE; Lassen JF
Am J Cardiol; 2009 Dec; 104(12):1641-6. PubMed ID: 19962468
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
[TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis in an ST-segment elevation myocardial infarction population treated with routine primary percutaneous coronary intervention: from clinical trial to real-life experience.
Pedersen S; Galatius S; Mogelvang R; Davidsen U; Galloe A; Abildstrom SZ; Abildgaard U; Hansen PR; Bech J; Iversen A; Jorgensen E; Kelbaek H; Saunamaki K; Madsen JK; Jensen JS
Circ Cardiovasc Interv; 2009 Oct; 2(5):392-400. PubMed ID: 20031748
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent changes of myeloperoxidase in relation to in-hospital mortality in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Ignjatovic S; Mrdovic I; Matic D; Savic L; Marinkovic J; Ostojic M; Vasiljevic Z
Clin Biochem; 2012 May; 45(7-8):547-51. PubMed ID: 22394459
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Fefer P; Hod H; Hammerman H; Segev A; Beinart R; Boyko V; Behar S; Matetzky S
Am J Cardiol; 2009 Aug; 104(4):514-8. PubMed ID: 19660604
[TBL] [Abstract][Full Text] [Related]
13. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes.
Ndrepepa G; Braun S; Mehilli J; von Beckerath N; Schömig A; Kastrati A
Eur J Clin Invest; 2008 Feb; 38(2):90-6. PubMed ID: 18226042
[TBL] [Abstract][Full Text] [Related]
15. Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
Brener SJ; Westerhout CM; Fu Y; Todaro TG; Moliterno DJ; Wagner GS; Granger CB; Armstrong PW;
Am Heart J; 2009 Nov; 158(5):755-60. PubMed ID: 19853693
[TBL] [Abstract][Full Text] [Related]
16. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Appelbaum E; Abraham JM; Pride YB; Harrigan CJ; Peters DC; Biller LH; Manning WJ; Gibson CM
Am Heart J; 2009 Jul; 158(1):84-91. PubMed ID: 19540396
[TBL] [Abstract][Full Text] [Related]
17. Distortion of the terminal portion of the QRS is predictor of shock after primary percutaneous coronary intervention for acute myocardial infarction.
Garcia-Rubira JC; Garcia-Borbolla R; Nuñez-Gil I; Manzano MC; Garcia-Romero MM; Fernandez-Ortiz A; Perez de Isla L; Macaya C
Int J Cardiol; 2008 Nov; 130(2):241-5. PubMed ID: 18068246
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Majkic-Singh N; Ignjatovic S; Mihailovic M; Nikolajevic I; Mrdovic I; Matic D; Savic L; Marinkovic J; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(1-2):125-31. PubMed ID: 22372355
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention.
Hassan AK; Bergheanu SC; Hasan-Ali H; Liem SS; van der Laarse A; Wolterbeek R; Atsma DE; Schalij MJ; Jukema JW
Am J Cardiol; 2009 Mar; 103(6):779-84. PubMed ID: 19268731
[TBL] [Abstract][Full Text] [Related]
20. Level of complement activity predicts cardiac dysfunction after acute myocardial infarction treated with primary percutaneous coronary intervention.
Haahr-Pedersen S; Bjerre M; Flyvbjerg A; Mogelvang R; Dominquez H; Hansen TK; Galatius S; Bech J; Madsen JK; Søgaard P; Jensen JS
J Invasive Cardiol; 2009 Jan; 21(1):13-9. PubMed ID: 19126922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
